Experience

Alexander Davis

    • Inhibrx – $137 Million IPO 


    • ALX Oncology – $186 Million IPO 


    • Avidity Biosciences - $289 Million IPO 


    • The Underwriters On Guardant Health's $1.1 Billion Follow-On Offering 


    • The Underwriters On Livongo Health's $550 Million Convertible Senior Notes 


    • Vir Biotechnology - $143 Million IPO 


    • Exagen Diagnostics – $58 Million IPO  


    • Satsuma Pharmaceuticals – $83 Million IPO  


    • 10X Genomics – $449 Million IPO  


    • Health Catalyst - $209 Million IPO 


    • Gossamer Bio – $317 Million IPO 


    • Tricida – $256 Million IPO